A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia Journal Articles Refereed uri icon

Overview

Published in

  • Value in Health

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.jval.2016.05.013

Additional Document Info

Parent Title

  • VALUE IN HEALTH

Volume

  • 19

Issue

  • 8

Publisher

  • Wiley-Blackwell Publishing